Report, if you have a problem with this page“ Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies ”
Jennifer A. Doudna
From : A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution
